Hospira Hosts Conference Call for Second-Quarter Earnings
12 Julho 2005 - 12:09PM
PR Newswire (US)
Hospira Hosts Conference Call for Second-Quarter Earnings LAKE
FOREST, Ill., July 12 /PRNewswire-FirstCall/ -- Hospira, Inc.
(NYSE:HSP), one of the largest hospital products manufacturers in
the United States, today announced that it will release its 2005
second-quarter financial results on Thursday, Aug. 11, 2005, before
the U.S. stock market opens. A conference call featuring remarks by
senior management will be held with investors and the media that
same day at 9 a.m. Central Time. A live webcast of the conference
call will be available at http://www.hospirainvestor.com/ .
Listeners should log on approximately 10 minutes in advance to
ensure proper computer setup to receive the webcast. A replay will
be available on the Hospira Web site for 30 days following the
call. About Hospira Hospira, Inc. is a global specialty
pharmaceutical and medication delivery company dedicated to
Advancing Wellness(TM) by developing, manufacturing and marketing
products that help improve the productivity, safety and efficacy of
patient care. With 70 years of service to the hospital industry,
Hospira's portfolio includes one of the industry's broadest lines
of generic acute-care injectables, which help address the high cost
of proprietary pharmaceuticals in hospitals; integrated solutions
for medication management and infusion therapy; and the leading
U.S. injectable contract manufacturing business. Headquartered in
Lake Forest, Ill., north of Chicago, Hospira has approximately
13,000 employees and 14 manufacturing facilities worldwide.
Hospira's news releases and other information can be found at
http://www.hospira.com/ . Private Securities Litigation Reform Act
of 1995 -- A Caution Concerning Forward-Looking Statements Some
statements in this news release may be forward-looking statements
for purposes of the Private Securities Litigation Reform Act of
1995. Hospira cautions that these forward-looking statements are
subject to risks and uncertainties that may cause actual results to
differ materially from those indicated in the forward-looking
statements. Economic, competitive, governmental, technological and
other factors that may affect Hospira's operations and may cause
actual results to be materially different from expectations include
the risks and uncertainties set forth under the heading "Item 1
Business -- Risk Factors" in Hospira's Annual Report on Form 10-K
for the year ended Dec. 31, 2004, filed with the Securities and
Exchange Commission, which are incorporated by reference. Hospira
undertakes no obligation to release publicly any revisions to
forward-looking statements as the result of subsequent events or
developments. http://www.newscom.com/cgi-bin/prnh/20040503/HSPLOGO
http://photoarchive.ap.org/ DATASOURCE: Hospira, Inc. CONTACT:
Media, Stacey Eisen, +1-224-212-2276, or Tareta Adams,
+1-224-212-2535, or Financial Community, Lynn McHugh,
+1-224-212-2363, all of Hospira, Inc. Web site:
http://www.hospira.com/ http://www.hospirainvestor.com/
Copyright
Hospira (NYSE:HSP)
Gráfico Histórico do Ativo
De Jun 2024 até Jul 2024
Hospira (NYSE:HSP)
Gráfico Histórico do Ativo
De Jul 2023 até Jul 2024
Notícias em tempo-real sobre da New York Stock Exchange bolsa de valores: 0 artigos recentes
Mais Notícias de Hospira